April 2010 Briefing - NephrologyLast Updated: May 03, 2010.
Here are what the editors at HealthDay consider to be the most important developments in Nephrology for April 2010. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.
Cancer Risks Similar With Different Immunosuppressants
FRIDAY, April 30 (HealthDay News) -- The long-term risk of cancer after a kidney transplant does not vary among three different immunosuppressive regimens, according to a study published online April 29 in the Journal of the American Society of Nephrology.
In Children With CKD, Race Linked to Hemoglobin Levels
WEDNESDAY, April 28 (HealthDay News) -- African-American children with chronic kidney disease (CKD) have lower hemoglobin levels than white children with the disease, regardless of the disease's underlying cause, according to a study published online April 26 in the American Journal of Kidney Diseases.
Risk Factors for Physician Misconduct Identified
WEDNESDAY, April 28 (HealthDay News) -- Doctors who are male, are from lower socioeconomic groups or had academic difficulties in medical school may be at increased risk of professional misconduct, according to a study published online April 27 in BMJ.
Vitamin B Therapy May Be Unsafe in Diabetic Nephropathy
TUESDAY, April 27 (HealthDay News) -- Patients with diabetic nephropathy who take high doses of vitamin B may experience a greater decrease in glomerular filtration rate (GFR) than those on placebo, as well as an increase in vascular events, according to research published in the April 28 issue of the Journal of the American Medical Association.
FDA Changes Medical Device Advisory Committee Process
TUESDAY, April 27 (HealthDay News) -- Because of the increasing number of medical device advisory panel meetings in recent years, the U.S. Food and Drug Administration is changing the way expert panels review and discuss information during public hearings on devices that are being reviewed for premarket approval.
Interruptions Increase Medication Errors by Nurses
TUESDAY, April 27 (HealthDay News) -- Nurses who are interrupted in the process of preparing and administering medications are more likely to make an error, with error severity increasing with the number of interruptions, according to a study in the April 26 issue of the Archives of Internal Medicine.
Financial Ties Negatively Affect Perceptions of Research Quality
TUESDAY, April 27 (HealthDay News) -- Disclosure of financial ties to industry influences patients', physicians', and research participants' beliefs about the quality of research evidence, according to a review published in the April 26 issue of the Archives of Internal Medicine.
Most Doctors Not Knowledgeable About Herbals
MONDAY, April 26 (HealthDay News) -- Most physicians are not knowledgeable about herbal medicines and believe the general public is poorly informed as well, according to the results of a survey published in the April issue of the Drug and Therapeutics Bulletin.
Urologist Presence Linked to Less Urologic Cancer Mortality
THURSDAY, April 22 (HealthDay News) -- The presence of a urologist in a county is linked to lower mortality for prostate, bladder and kidney cancer, though increasing urologist density beyond two urologists per 100,000 people does not result in further improvements, according to research published online April 20 in the Journal of Clinical Oncology.
Weekend Admission Affects Mortality in Acute Kidney Injury
FRIDAY, April 16 (HealthDay News) -- Being admitted to the hospital on a Saturday or Sunday with acute kidney injury (AKI) is associated with an increased risk of in-hospital mortality compared to being admitted on a weekday, according to a study published online April 15 in the Journal of the American Society of Nephrology.
Many Kidney Diseases Caused by Single-Gene Defects
FRIDAY, April 9 (HealthDay News) -- Many genetic kidney diseases are caused by single-gene defects, which means those defects can be targeted in disease treatments, according to an article published in the April 10 kidney medicine special issue of The Lancet. According to another article in the same issue, in low- and middle-income countries, most patients with chronic kidney disease (CKD) die without receiving dialysis or transplantation because of limited availability.
Many Transplant Patients Open to Possibly Infected Kidney
FRIDAY, April 2 (HealthDay News) -- The majority of renal transplant candidates are open to accepting a kidney from a donor at increased risk for blood-borne viral infections such as HIV under some circumstances, but many donor kidneys infected with hepatitis C are thrown away despite the need among hepatitis C patients awaiting transplants, according to two studies published, respectively, online March 25 in the Clinical Journal of the American Society of Nephrology and March 26 in the American Journal of Transplantation.
|Previous: April 2010 Briefing - Otolaryngology||Next: April 2010 Briefing - Pathology|
Reader comments on this article are listed below. Review our comments policy.